Defining eukaryotes to dissect eukaryogenesis
Current Biology · 2023-09 · 33 (17) · R919-R929
DOI: 10.1016/j.cub.2023.07.048 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Biology, 2023-09. Verfasst von Philip C J Donoghue und 7 weiteren Autor:innen. Beteiligte Einrichtung: Bristol Palaeobiology Group, School of Earth Sciences, Life Sciences Building, University of Bristol, Bristol BS8 1TQ, UK. Electronic address: Phil.D…. Hauptthemen laut MEDLINE: Eukaryota, Eukaryotic Cells. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: Biotechnology and Biological Sciences Research Council, Gordon and Betty Moore Foundation, Leverhulme Trust.
Abstract (Originalsprache)
The origin of eukaryotes is among the most contentious debates in evolutionary biology, attracting multiple seemingly incompatible theories seeking to explain the sequence in which eukaryotic characteristics were acquired. Much of the controversy arises from differing views on the defining characteristics of eukaryotes. We argue that eukaryotes should be defined phylogenetically, and that doing so clarifies where competing hypotheses of eukaryogenesis agree and how we may test among aspects of disagreement. Some hypotheses make predictions about the phylogenetic origins of eukaryotic genes and are distinguishable on that basis. However, other hypotheses differ only in the order of key evolutionary steps, like mitochondrial endosymbiosis and nuclear assembly, which cannot currently be distinguished phylogenetically. Stages within eukaryogenesis may be made identifiable through the absolute dating of gene duplicates that map to eukaryotic traits, such as in genes of host or mitochondrial origin that duplicated and diverged functionally prior to emergence of the last eukaryotic common ancestor. In this way, it may finally be possible to distinguish heat from light in the debate over eukaryogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Bristol Palaeobiology Group, School of Earth Sciences, Life Sciences Building, University of Bristol, Bristol BS8 1TQ, UK. Electronic address: Phil.Donoghue@bristol.ac.uk.
- Bristol Palaeobiology Group, School of Earth Sciences, Life Sciences Building, University of Bristol, Bristol BS8 1TQ, UK.
- Department of Marine Microbiology and Biogeochemistry, NIOZ, Royal Netherlands Institute for Sea Research, Utrecht University, Den Burg 1790 AB, The Netherlands.
- Department of Biological Physics, Eötvös Lorand University, H-1117 Budapest, Hungary; MTA-ELTE "Lendü let" Evolutionary Genomics Research Group, H-1117 Budapest, Hungary; Institute of Evolution, Centre for Ecological Re…
- Bristol Palaeobiology Group, School of Earth Sciences, Life Sciences Building, University of Bristol, Bristol BS8 1TQ, UK; Bristol Palaeobiology Group, School of Biological Sciences, Life Sciences Building, University o…
- Bristol Palaeobiology Group, School of Biological Sciences, Life Sciences Building, University of Bristol, Bristol BS8 1TQ, UK. Electronic address: tom.a.williams@bristol.ac.uk.
Förderung
- Biotechnology and Biological Sciences Research Council
- Gordon and Betty Moore Foundation
- Leverhulme Trust
- John Templeton Foundation
Zitieren
APA
Donoghue, P. C. J., Kay, C., Spang, A., Szöllősi, G., Nenarokova, A., Moody, E. R. R., Pisani, D., & Williams, T. A. (2023). Defining eukaryotes to dissect eukaryogenesis. Current Biology, 33(17), R919-R929. https://doi.org/10.1016/j.cub.2023.07.048
Vancouver
Donoghue PCJ, Kay C, Spang A, Szöllősi G, Nenarokova A, Moody ERR, et al. Defining eukaryotes to dissect eukaryogenesis. Current Biology. 2023;33(17):R919-R929. doi:10.1016/j.cub.2023.07.048
BibTeX
@article{Donoghue2023,
author = {Donoghue, Philip C J and Kay, Chris and Spang, Anja and Szöllősi, Gergely and Nenarokova, Anna and Moody, Edmund R R and Pisani, Davide and Williams, Tom A},
title = {Defining eukaryotes to dissect eukaryogenesis},
journal = {Current Biology},
year = {2023},
volume = {33},
number = {17},
pages = {R919--R929},
doi = {10.1016/j.cub.2023.07.048}
}
EUVIMED